GlassScriptPhysician profile
Laura J Friedlander
NPI 1578852042
$4,507.57
in general payments reported to CMS, 2019-2025
17 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $1,020 · 2021: $349 · 2022: $192 · 2023: $438 · 2024: $1,354 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,489 · Travel and Lodging: $258 · Education: $47.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,488.88 |
| Travel and Lodging | $257.79 |
| Education | $47.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,021.64 | 2019-2020 | |
| Ucb, INC. | $994.15 | 2019-2025 | Fintepla, Nayzilam, Briviact |
| Sk Life Science, INC. | $936.38 | 2020-2025 | |
| Neuropace, INC. | $868.74 | 2020-2025 | |
| Neurelis, INC. | $147.88 | 2021-2024 | Valtoco |
| Catalyst Pharmaceuticals, INC. | $87.27 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $75.51 | 2025 | Austedo Xr |
| Medtronic, INC. | $66.79 | 2021-2023 | Percept PC Brainsense |
| Celgene Corporation | $54.56 | 2022-2024 | Reblozyl |
| Pfizer INC. | $54.44 | 2023-2025 | |
| Aucta Pharmaceuticals, INC. | $39.27 | 2025 | Motpoly Xr |
| Lilly USA, LLC | $32.78 | 2019-2020 | |
| Livanova USA, INC. | $32.69 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Biogen, INC. | $29.53 | 2024 | Tysabri, Vumerity |
| Abbvie INC. | $29.10 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $19.23 | 2024 | |
| Amgen INC. | $17.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Friedlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.